Protocol · PharmD · Vermont
Practice Protocol for Pharmacists in Vermont
Required. Vermont law names the instrument a Written Collaborative Practice Agreement, and the clinical protocol is the content that instrument carries. Below: the board that governs it, what it must contain, and the terms it has to carry.
Represents Vermont's Collaborative Practice Agreement (CPA) tier under 26 V.S.A. § 2023, not ordinary pharmacist licensure — base dispensing and statutory protocol-based authority (e.g. vaccines, naloxone) need no agreement and are out of scope here. Pharmacists may not initiate antibiotic therapy or prescribe regulated drugs/biologics except under a CPA. No board-certification or numeric per-prescriber cap found.
What a Vermont Written Collaborative Practice Agreement must contain
Governed by the Vermont Board of Pharmacy. Each numbered item is a statutory requirement the Written Collaborative Practice Agreement must satisfy.
The Pharmacist shall practice collaborative pharmacy practice pursuant to a written collaborative practice agreement with the Physician, as authorized by 26 V.S.A. chapter 36 and the Vermont Board of Pharmacy's administrative rules for clinical pharmacy. The agreement shall be valid for no more than one (1) year at a time, after which the Parties must execute a new written agreement for collaborative pharmacy practice to continue, and the Pharmacist may hold separate collaborative practice agreements with more than one practitioner.
The agreement shall require the Pharmacist and the Physician to contemporaneously notify each other of any change in the patient's pharmacotherapy or known medical status, and shall provide for no less than an annual quality assurance review of the services provided under the agreement by the Physician.
- The Written Collaborative Practice Agreement also carries 1 scope, 1 education and 1 registration clauses, authored in the document itself.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the Written Collaborative Practice Agreement has to carry, from Vermont's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · no controlled-substance authority
Statute text located does not affirmatively authorize controlled-substance prescribing under a Vermont CPA — coded as not allowed pending confirmation; verify against current Board of Pharmacy rules before relying on this for a controlled-substance scenario.
Written agreement
Required
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — No pharmacist-ownership requirement identified for Vermont pharmacy permits; H.583 targets 'medical practices', not pharmacies
Pharmacy ownership was not separately researched in the depth given to the medical/APRN CPOM entries above — flagged as lower confidence.
Sources for the supervision rules (2)
About Vermont's rules
H.583 (signed June 15, 2026, eff. July 1, 2026) newly restricts private-equity/hedge-fund control and requires majority physician ownership/governance of medical practices — a major shift from Vermont's historically permissive, no-common-law-CPOM stance. All 4 APRN roles (NP, CRNA, CNM, CNS/PMHNP) share one 2,400-hour/2-year transition-to-practice threshold (26 V.S.A. § 1614) — treat as newly in effect and monitor implementing guidance.
Other clinicians in Vermont: see the state overview.